Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function.

Morgan WJ, VanDevanter DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW; Scientific Advisory Group.; Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2016 Feb;169:116-21.e2. doi: 10.1016/j.jpeds.2015.08.042.

PMID:
26388208
2.

Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.

Tonelli AR, Alkukhun L, Arelli V, Ramos J, Newman J, McCarthy K, Pichurko B, Minai OA, Dweik RA.

Clin Transl Sci. 2013 Dec;6(6):474-80. doi: 10.1111/cts.12090.

3.

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC.; ESCF Investigators..

Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693.

4.

Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.

Morgan WJ, Wagener JS, Yegin A, Pasta DJ, Millar SJ, Konstan MW; Scientific Advisory Group, investigators.; coordinators of the Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2013 Oct;163(4):1152-7.e2. doi: 10.1016/j.jpeds.2013.05.013.

5.

Exercising your patient: which test(s) and when?

Pichurko BM.

Respir Care. 2012 Jan;57(1):100-10; discussion 110-3. doi: 10.4187/respcare.01428. Review.

6.

Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis.

Schechter MS, McColley SA, Regelmann W, Millar SJ, Pasta DJ, Wagener JS, Konstan MW, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2011 Nov;159(5):819-824.e1. doi: 10.1016/j.jpeds.2011.05.005.

7.

Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.

Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.; North American Scientific Advisory Group for ESCF..

J Pediatr. 2009 Nov;155(5):634-9.e1-4. doi: 10.1016/j.jpeds.2009.04.059.

8.

Perceived exertion and muscle efficiency in Parkinson's disease: L-DOPA effects.

LeWitt PA, Bharucha A, Chitrit I, Takis C, Patil S, Schork MA, Pichurko B.

Clin Neuropharmacol. 1994 Oct;17(5):454-9.

PMID:
9316695
9.

Relationship among mediators, inflammation, and volume history with antigen versus hyperpnea challenge in guinea pigs.

Ingenito EP, Godleski JJ, Pliss LB, Pichurko BM, Ingram RH Jr.

Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1315-9.

PMID:
1443890
10.

Assessment of bronchoalveolar cell and mediator response to isocapnic hyperpnea in asthma.

Pliss LB, Ingenito EP, Ingram RH Jr, Pichurko B.

Am Rev Respir Dis. 1990 Jul;142(1):73-8.

PMID:
2114811
11.

Bronchoalveolar lavage cell and mediator responses to hyperpnea-induced bronchoconstriction in the guinea pig.

Ingenito EP, Pliss LB, Ingram RH Jr, Pichurko BM.

Am Rev Respir Dis. 1990 May;141(5 Pt 1):1162-6.

PMID:
2339838
12.

Breathing pattern affects respiratory heat loss but not bronchoconstrictor response in asthma.

Ingenito EP, Pichurko BM, Lafleur J, Drazen JM, Ingram RH Jr, Solway J.

Lung. 1990;168(1):23-34.

PMID:
2105410
13.

Localization of the site of the bronchoconstrictor effects of leukotriene C4 compared with that of histamine in asthmatic subjects.

Pichurko BM, Ingram RH Jr, Sperling RI, Lafleur JE, Corey EJ, Austen KF, Drazen JM.

Am Rev Respir Dis. 1989 Aug;140(2):334-9.

PMID:
2764369
14.

Respiratory mechanics in acute quadriplegia. Lung and chest wall compliance and dimensional changes during respiratory maneuvers.

Scanlon PD, Loring SH, Pichurko BM, McCool FD, Slutsky AS, Sarkarati M, Brown R.

Am Rev Respir Dis. 1989 Mar;139(3):615-20.

PMID:
2923360
15.

Dissociation of temperature-gradient and evaporative heat loss during cold gas hyperventilation in cold-induced asthma.

Ingenito E, Solway J, Lafleur J, Lombardo A, Drazen JM, Pichurko B.

Am Rev Respir Dis. 1988 Sep;138(3):540-6.

PMID:
3202410
16.

Indirect assessment of mucosal surface temperatures in the airways: theory and tests.

Ingenito EP, Solway J, McFadden ER Jr, Pichurko B, Bowman HF, Michaels D, Drazen JM.

J Appl Physiol (1985). 1987 Nov;63(5):2075-83.

PMID:
3693240
17.

Effects of airway tone and volume history on maximal expiratory flow in asthma.

Pichurko BM, Ingram RH Jr.

J Appl Physiol (1985). 1987 Mar;62(3):1133-40.

PMID:
3571070
18.

Finite difference analysis of respiratory heat transfer.

Ingenito EP, Solway J, McFadden ER Jr, Pichurko BM, Cravalho EG, Drazen JM.

J Appl Physiol (1985). 1986 Dec;61(6):2252-9.

PMID:
3804930
19.

Endogenous adrenergic modification of exercise-induced asthma.

Pichurko BM, Sullivan B, Porcelli RJ, McFadden ER Jr.

J Allergy Clin Immunol. 1986 Jun;77(6):796-801.

PMID:
3711547
20.

Changes in lung volume and rib cage configuration with abdominal binding in quadriplegia.

McCool FD, Pichurko BM, Slutsky AS, Sarkarati M, Rossier A, Brown R.

J Appl Physiol (1985). 1986 Apr;60(4):1198-202.

PMID:
3700303
Items per page

Supplemental Content

Loading ...
Support Center